In a systematic review by Pedersen et al[19] regarding the important pathways for the management of inflammatory bowel diseases, the authors highlight that TNF-alpha plays a key role in the inflammatory cascade that orchestrates chronic intestinal inflammation, pointing that anti-TNF-alpha agents are the most effective anti-cytokine treatment for these diseases. This evidence concerns the gene TNF and inflammatory bowel disease.